(Q74604115)
Statements
Neoadjuvant chemotherapy for operable breast carcinoma larger than 3 cm: a unicentre randomized trial with a 124-month median follow-up. Institut Bergonié Bordeaux Groupe Sein (IBBGS) (English)
L Mauriac
G MacGrogan
A Avril
M Durand
A Floquet
M Debled
J M Dilhuydy